| UCSF Magazine

Two New Guides Released to Help Older Patients with Cancer

Louise Walter, MD, chair of UCSF Geriatrics, served as vice-chair of the National Comprehensive Cancer Network (NCCN) Guidelines Panel for Older Adult Oncology, which recently new treatment guidelines for older adults with cancer.

UCSF Wins Big, From Gamechangers to Startups to Life Achievement

UCSF researchers earned four UC Regents Innovation Awards for breakthroughs in precision cancer treatment, rapid diagnostics, disease prevention and multiple sclerosis care.

Can Psychedelic Clinical Trials Be Better? Researchers Say Yes

UCSF researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing control treatments to better measure the drugs' true effects.

A Gift to Help Scientists Predict How Drugs Behave in the Body

OpenADMET, helmed by Jaime Fraser, will receive funding from the OpenAI Foundation in pursuit of an efficient, affordable, open system for screening thousands of drugs for their ability to safely traverse the body to treat disease. This transit of drugs in the human body is often where new drugs fail in clinical trials.

Brain Activity Can Predict a Risky Decision Before It’s Made

How does your brain decide whether to hit “send” on a risky email or delete the draft? Two neighboring parts of it argue with each other until one overrules the other. Researchers created a video game to see what players’ brains were doing while making risk-reward decisions.

UCSF Benioff Children’s Hospitals Earn Strongest US News Rankings

UCSF Benioff Children’s Hospitals earned its strongest-ever showing in the 2026-27 U.S. News Best Children’s Hospitals rankings, tying for best in Northern California, with all specialties nationally recognized and four ranking in the top 10.

To Work Their Best, Busy Body Tissues Call on Bigger Cleanup Crews

UCSF researchers discover how some of our hardest-working organs stay healthy: by recruiting immune macrophages to dispose of spent batteries (mitochondria) while heart/muscle/fat cells burn energy.

FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data

UC San Francisco study data was instrumental in today’s approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer.

The approval of floretyrosine F 18 (18F-FET) was supported by prospective clinical trial data generated at UCSF through a multi-year study. The agent addresses a persistent challenge in caring for people with gliomas: determining whether changes seen on conventional imaging represent tumor growth or changes caused by treatment.

UCSF Expands Transit Pass Program Across its Workforce

UCSF is expanding Clipper BayPass to 36,000 employees and students, offering affordable, unlimited public transit across 24 Bay Area bus, rail and ferry services.

UCSF Expands Behavioral Health Support Program for Families Statewide

A UCSF-developed program that integrates behavioral health support for children and caregivers into routine pediatric care is poised to extend across California with a $17 million investment from the California Department of Health Care Services (DHCS).